In Brief: IFRA NA Supports Cosmetics Bill; Coty CEO Named; John Frieda Recall; More
This article was originally published in The Rose Sheet
Executive Summary
The Personal Care Products Safety Act’s ingredient-reporting requirements pose no obvious threat to trade secrets in the fragrance sector, according to the International Fragrance Association North America; Coty names CEO. More news in brief.
You may also be interested in...
Sen. Feinstein’s Cosmetics Safety Bill Launches With GOP Cosponsor
The Personal Care Products Safety Act would preempt duplicative state-level requirements for ingredient use and manufacturer responsibilities, addressing what has become one of the foremost banes of industry in recent years, while increasing FDA’s authority over the sector and giving it new responsibilities with regard to ingredient safety review. Additional compliance requirements for industry could prove challenging, but the positive PR likely to result from the legislation could help soften the blow.
Investors Go Beserk For Viking, Putting It Top Of Q1 Winners
The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.